H.C. Wainwright Reiterates Buy Rating, $9 Price Target on Unicycive Therapeutics (UNCY)
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $9.00 price target on Unicycive Therapeutics (NASDAQ: UNCY). The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
